| Subject: | Nationwide Recall of Cefazolin for Injection |
| Category: | Food and Drug Administration (FDA)
|
| Published: | Thu, 2 Mar 2006 - 10:00 am |
| On February 24, 2006 Hanford Pharmaceuticals Inc., of Syracuse, NY, voluntarily recalled four lots (379,975 vials) of Cefazolin for Injection, USP, 1 g/10 mL vials, an antibiotic used in a hospital environment.
Certain lots of the active ingredient used to manufacture the product have been shown to contain microbial contamination (Bacillus pumilus, Staphylococcus hominis, Propionibacterium acnes, or Micrococcus luteus), which may pose a serious or life- threatening risk for some patients.... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
REFERENCE:
Policies / Forms / Additional Resources:
|
|
StayAlert! provides immediate notification of regulatory body legislation impacting the healthcare industry, helping you to meet regulatory compliance. Subscribers are notified of any new or revised regulations, provided with a summary of the regulation, followed by an implementation action plan and/or policy. Designed as an e-mail "push" method for rapid customer notification of healthcare compliance issues, paired with interpretative analysis and practical application, the StayAlert!® Virtual Compliance Administrator™ saves you time and money. Other vendors have components of legislated requirements available online or on CD-ROM. However there is no other product that marries regulatory agency mandates with implementation tools, making the latest compliance information immediately available online. No other product provides an interpretative analysis, followed by a practical application tool, therefore providing users with an immediate solution to compliance problems. StayAlert! includes operational components for healthcare organizations, allowing complete facility compliance with mandated requirements, online. |
|
